Default company panoramic image
Logo

Calpain Therapeutics

The first pharmaceutical treatment for cataract.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Adelaide, South Australia, Australia
  • Currency AUD
  • Founded August 2011
  • Employees 1
  • Website calpaintherapeutics.com

Company Summary

Calpain Therapeutics is a privately-held venture dedicated to bringing to market a set of proprietary chemical compounds that effectively and selectively inhibit Calpain – a family of cysteine proteases which are present in the cytoplasma of many tissues. Calpain Therapeutics aims to bring to market new chemical entities that dramatically slow the progression of ophthalmic and neurodegenerative related diseases caused by Calpain.

Team

Advisors

  • Default avatar
    Piper Alderman
    Lawyer
    Unconfirmed
    Default avatar
    Worrell & Co
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Enterprize Business Competition Winner $100,000
    Unconfirmed
    Default avatar
    Commercialisation Australia Grant $190,250
    Unconfirmed